Global equity funds attracted inflows for an 11th successive week through Dec. 11, supported by signs that a cooling U.S. labor market and stable consumer prices might facilitate a third consecutive rate cut by the Federal Reserve this month. Investors snapped up global equity funds worth a net $10.18 billion during the week, following about $21.19 billion worth of net purchases in the prior week, LSEG Lipper data showed. Last week's U.S. employment report showed a surge in job growth for November, rebounding from disruptions caused by hurricanes and strikes, but the unemployment rate increased to 4.2%, signaling a loosening labor market that could prompt the Federal Reserve to cut interest ...
As accusations of ‘debanking’ grip Silicon Valley, the crypto industry is still waiting for a smoking gun
Did regulators prevent banks from working with crypto companies and founders for political reasons?
Fed to Cut Once More Before Slowing Pace in 2025, Economists Say
(Bloomberg) -- Federal Reserve officials will lower interest rates this month for a third straight time and pare back the number of rate cuts they anticipate next year, according to economists surveyed by Bloomberg News.Most Read from BloombergHong Kong's Expat Party Hub Reshaped by Chinese InfluxBrace for a Nationwide Shuffle of Corporate HeadquartersHow California Sees the World, and ItselfCity Hall Is HiringAmerican Institute of Architects CEO ResignsFed Chair Jerome Powell and his colleagues
Bitcoin Hits $102K: Texas Makes History, BlackRock Bets Big, and Riot Faces a Shocking Ultimatum
From Texas's bold adoption plan to BlackRock's continued backing, bitcoin's solid performance and rising demand underscore its prominence in the digital asset space. Meanwhile, Riot faces pressure to pivot to AI, and Microsoft stays cautious, rejecting bitcoin for its balance sheet.
Crypto Daybook Americas: Bull Momentum Stalls Ahead of Fed Rate Cut
Your day-ahead look for Dec. 13, 2024
Larger Cohorts Than U.S. ETFs or MicroStrategy Are Dictating Bitcoin Price: Van Straten
Since September, MicroStrategy and U.S.-listed spot ETFs have accumulated approximately 200,000 bitcoin each.
Here's What the Latest Bitcoin Rally Can Tell Us About the State of Crypto in 2025
The recent Bitcoin (CRYPTO: BTC) post-election rally has crypto investors looking ahead with anticipation to 2025. Bitcoin is up 125% for the year as of Dec. 10 and has finally broken through the psychologically important $100,000 price level to set a new all-time high. Will Bitcoin turn in an encore performance and once again deliver triple-digit returns?
Americans are sour on tariffs if they spark inflation, Reuters/Ipsos poll finds
Americans don't think import tariffs are a good idea if they lead to higher prices and are skeptical they would help U.S. workers, a Reuters/Ipsos poll found, underscoring the political risks to President-elect Donald Trump's plan to impose heavy fees on goods from China, Mexico and other nations. Only 29% of respondents in the six-day poll, which closed on Tuesday, agreed with a statement that "it’s a good idea for the U.S. to charge higher tariffs on imported goods even if prices increase," while 42% disagreed. Just 17% of respondents agreed with a statement that "when the U.S. charges tariffs on imported goods, it is good for me personally."
Fee War Kicks Off for One of Wall Street’s Hottest ETF Trades
(Bloomberg) -- Single-stock ETFs have been one of Wall Street’s hottest trades this year thanks to eye-popping returns and billions of dollars in inflows. Now, one issuer is kicking off a fee war in a bid to stand out and attract new cash. Most Read from BloombergHong Kong's Expat Party Hub Reshaped by Chinese InfluxHow California Sees the World, and ItselfBrace for a Nationwide Shuffle of Corporate HeadquartersCity Hall Is HiringAmerican Institute of Architects CEO ResignsLeverage Shares, which
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
Morgan Stanley downgraded Amicus Therapeutics Inc (NASDAQ:FOLD). Over the last year, the company has executed well commercially, met its goals financially by achieving nonGAAP profitability for 2024, and settled its Galafold patent litigation with Teva Pharmaceutical Industries Ltd. The analyst notes that Amicus is well-positioned, but expectations have increased with the company’s progress, which are now largely priced into shares. The analyst downgraded the stock to Equal-weight from Overweigh